Public governance artifact
Gender Equality Plan 2026-2028
The plan is published as a formal document and as a readable public route so partners, funders, and future team members can review SmartClover's equality commitments in the open.
SmartClover is led by identifiable leadership and supported by public research continuity, visible product artifacts, and governance materials. This page summarizes the company's operating context, evidence base, and delivery posture.
Leadership and research continuity
SmartClover links its public healthcare positioning to named research and a visible flagship product. Dr. Andreea Damian appears in public literature directly and also through earlier work published under the name Andreea Itu. That continuity connects the company's cervical screening direction to identifiable prior work.
Dr. Florian Nicula also appears in the public research record that informs the screening and follow-up context. Together, these references give clinicians, partners, and investors a clearer basis for evaluation.

BMJ Open protocol on follow-up barriers after abnormal cervical screening in remote Romanian communities.
Social Science & Medicine research on cervical screening participation in Romania.
Implementation-facing artifact for the flagship product surface.
Reusable BibTeX source for public citation continuity.
SmartClover is led by a female founder and CEO. The public Gender Equality Plan documents commitments on recruitment, leadership, organisational culture, monitoring, training, and measures against gender-based violence and sexual harassment.
Public governance artifact
The plan is published as a formal document and as a readable public route so partners, funders, and future team members can review SmartClover's equality commitments in the open.
Why it matters
SmartClover links leadership credibility to concrete governance: annual monitoring, inclusive recruitment practice, awareness training, and a defined reporting route for misconduct concerns.
The main public continuity points are presented in one place.
Research continuity
Public research from 2017 and 2022 provides a visible continuity line into SmartClover’s healthcare focus.
Productization
The company moved from research intent into a live product surface with workflow evidence and a public implementation trail.
Company shape
DataGems, trust routes, pricing, buying, and blog surfaces present the company as a broader operating platform.
Current stance
The public site emphasizes named leadership, public artifacts, and a realistic delivery posture across the business.
Values matter most when they are attached to leadership, products, and a visible operating model.
SmartClover makes room for original thinking, but each initiative still has to withstand review by buyers, researchers, and clinical operators.
The company focuses on turning difficult workflows into maintainable digital systems rather than delivering one-off experiments.
Clinicians, researchers, and operators remain decision owners while AI accelerates triage, communication, and analysis.
SmartClover states these principles publicly so partners can understand how products are built, deployed, and governed.
Product ownership
SmartClover uses product surfaces, public repositories, and defined operating boundaries instead of presenting itself as a broad, unscoped AI consultancy.
Evidence before claims
Citations, current product proof, and dated trust material support public claims where accuracy matters most.
Trust-aware deployment
Security, privacy, governance, and procurement routes remain visible so evaluators can review the company early.
About establishes confidence. CerviGuard, Trust, and Contact turn that confidence into product evaluation, diligence, and conversation.